TY - JOUR
T1 - Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics
T2 - A Patient-Randomized Controlled Trial
AU - Rogers, Erin S.
AU - Smelson, David A.
AU - Gillespie, Colleen C.
AU - Elbel, Brian
AU - Poole, Senaida
AU - Hagedorn, Hildi J.
AU - Kalman, David
AU - Krebs, Paul
AU - Fang, Yixin
AU - Wang, Binhuan
AU - Sherman, Scott E.
N1 - Funding Information:
This trial was funded by the U.S. Department of Veterans Affairs Health Services Research and Development Quality Enhancement Research Initiative (#SDP 07-034). The views expressed within are solely those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Dr. Kalman was affiliated with the Edith Nourse Rogers Memorial Veterans Hospital during the study. Dr. Poole was affiliated with the VA NY Harbor Healthcare System and New York University School of Medicine Department of General Internal Medicine during the study.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Introduction People with a mental health diagnosis have high rates of tobacco use and encounter limited availability of tobacco treatment targeted to their needs. This study compared the effectiveness of a specialized telephone smoking-cessation intervention developed for mental health patients with standard state quit-line counseling. Design RCT. Setting/participants The study was conducted at six Veterans Health Administration facilities in the Northeast U.S. Participants were 577 mental health clinic patients referred by their providers for smoking-cessation treatment. Intervention From 2010 to 2012, the study implemented a telephone program that included patient referral from a mental health provider, mailed cessation medications, and telephone counseling. Participants were randomized to receive a specialized multisession telephone counseling protocol (n=270) or transfer to their state's quit-line for counseling (n=307). Main outcome measures Participants completed telephone surveys at baseline, 2 months, and 6 months. The study's primary outcome was self-reported 30-day abstinence at 6 months. Secondary outcomes were self-reported 30-day abstinence, counseling satisfaction and counseling content at 2 months, and self-reported use of cessation treatment and quit attempts at 6 months. Logistic regression was used to compare treatment groups on outcomes, controlling for baseline cigarettes per day and site. Inverse probability weighting and multiple imputation were used to handle missing abstinence outcomes. Data were analyzed in 2014-2015. Results At 6 months, participants in the specialized counseling arm were more likely to report 30-day abstinence (26% vs 18%, OR=1.62, 95% CI=1.24, 2.11). There was no significant group difference in abstinence at 2 months (18% vs 14%, OR=1.31, 95% CI=0.49, 3.49). Participants in the specialized arm were more likely to be assisted with developing a quit plan; receive follow-up calls after quitting; and receive counseling on several domains, including motivation, confidence, smoking triggers, coping with urges, and mental health symptoms (all p<0.05). Specialized counseling participants were more satisfied with treatment and more likely to find the counseling useful (p<0.05). Conclusions The specialized counseling intervention was more effective at helping patients quit than transfer to a state quit-line. Patients were more satisfied with the specialized counseling program. Trial registration This study is registered at www.clinicaltrials.gov NCT00724308.
AB - Introduction People with a mental health diagnosis have high rates of tobacco use and encounter limited availability of tobacco treatment targeted to their needs. This study compared the effectiveness of a specialized telephone smoking-cessation intervention developed for mental health patients with standard state quit-line counseling. Design RCT. Setting/participants The study was conducted at six Veterans Health Administration facilities in the Northeast U.S. Participants were 577 mental health clinic patients referred by their providers for smoking-cessation treatment. Intervention From 2010 to 2012, the study implemented a telephone program that included patient referral from a mental health provider, mailed cessation medications, and telephone counseling. Participants were randomized to receive a specialized multisession telephone counseling protocol (n=270) or transfer to their state's quit-line for counseling (n=307). Main outcome measures Participants completed telephone surveys at baseline, 2 months, and 6 months. The study's primary outcome was self-reported 30-day abstinence at 6 months. Secondary outcomes were self-reported 30-day abstinence, counseling satisfaction and counseling content at 2 months, and self-reported use of cessation treatment and quit attempts at 6 months. Logistic regression was used to compare treatment groups on outcomes, controlling for baseline cigarettes per day and site. Inverse probability weighting and multiple imputation were used to handle missing abstinence outcomes. Data were analyzed in 2014-2015. Results At 6 months, participants in the specialized counseling arm were more likely to report 30-day abstinence (26% vs 18%, OR=1.62, 95% CI=1.24, 2.11). There was no significant group difference in abstinence at 2 months (18% vs 14%, OR=1.31, 95% CI=0.49, 3.49). Participants in the specialized arm were more likely to be assisted with developing a quit plan; receive follow-up calls after quitting; and receive counseling on several domains, including motivation, confidence, smoking triggers, coping with urges, and mental health symptoms (all p<0.05). Specialized counseling participants were more satisfied with treatment and more likely to find the counseling useful (p<0.05). Conclusions The specialized counseling intervention was more effective at helping patients quit than transfer to a state quit-line. Patients were more satisfied with the specialized counseling program. Trial registration This study is registered at www.clinicaltrials.gov NCT00724308.
UR - http://www.scopus.com/inward/record.url?scp=84961113800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961113800&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2015.10.004
DO - 10.1016/j.amepre.2015.10.004
M3 - Article
C2 - 26711163
AN - SCOPUS:84961113800
SN - 0749-3797
VL - 50
SP - 518
EP - 527
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 4
ER -